Last quarter (Q ), Angion Biomedica's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Angion Biomedica's net income was $-4.54M. See Angion Biomedica’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 653.00K	$ 2.30M	$ 28.31M	$ 2.88M	$ 1.49M	$ 4.03M
Cost of Revenue	-	-	$ 433.00K	$ 1.19M	$ 640.00K	$ 378.00K
Gross Profit	-	-	$ 27.88M	$ 1.69M	$ 847.00K	$ 3.65M
Operating Expense	$ 21.21M	$ 32.74M	$ 67.19M	$ 56.96M	$ 39.44M	$ 17.99M
Operating Income	$ -20.56M	$ -32.74M	$ -39.31M	$ -55.27M	$ -38.59M	$ -14.34M
Net Non Operating Interest Income Expense	$ -5.00K	-	$ -1.85M	$ -8.85M	$ 265.00K	$ 252.00K
Other Income Expense	$ -3.17M	$ -2.55M	$ -13.42M	$ -15.99M	$ -2.33M	$ -5.93M
Pretax Income	$ -29.10M	$ -38.81M	$ -54.57M	$ -80.11M	$ -40.66M	$ -20.02M
Tax Provision	$ -7.41M	$ -7.41M	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	$ 151.00K	-	-	-	-
Net Income Common Stockholders	$ -29.10M	$ -38.81M	$ -54.57M	$ -80.11M	$ -40.66M	$ -25.00M
Basic EPS	$ -0.96	$ -1.29	$ -1.93	$ -2.78	$ -2.65	$ -1.63
Diluted EPS	$ -0.96	$ -1.29	$ -1.93	$ -2.78	$ -2.65	$ -1.63
Basic Average Shares	$ 120.24M	$ 30.04M	$ 28.24M	$ 28.78M	$ 15.36M	$ 15.36M
Diluted Average Shares	$ 120.24M	$ 30.04M	$ 28.24M	$ 28.78M	$ 15.36M	$ 15.36M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 21.21M	$ 32.74M	$ 67.62M	$ 58.15M	$ 40.08M	$ 18.37M
Net Income From Continuing And Discontinued Operation	$ -29.10M	$ -38.81M	$ -54.57M	$ -80.11M	$ -40.66M	$ -20.02M
Normalized Income	$ -14.83M	-	$ -52.31M	$ -75.81M	$ -38.69M	$ -18.26M
Interest Expense	-	-	-	-	-	-
EBIT	$ -26.81M	$ -39.61M	$ -39.31M	$ -55.27M	$ -38.59M	$ -14.34M
EBITDA	$ -25.98M	$ -38.60M	$ -38.51M	$ -54.65M	$ -38.09M	$ -14.34M

Currency in USD

Angion Biomedica Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing